- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Camurus
Market Cap: SEK 32.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 544.00
7D
2.1%
1Y
-8.1%
Vitrolife
Market Cap: SEK 11.8b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 87.95
7D
-5.0%
1Y
-35.0%
Swedish Orphan Biovitrum
Market Cap: SEK 163.0b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 471.20
7D
7.0%
1Y
70.0%
Bonesupport Holding
Market Cap: SEK 13.3b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 201.80
7D
-3.1%
1Y
-24.6%